The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Journal of Epidemiology and Global Health - Tập 12 - Trang 143-146 - 2022
Jaffar A. Al-Tawfiq1,2,3, Van-Thuan Hoang4, Nhat Le Bui5, Dinh-Toi Chu5, Ziad A. Memish6,7
1Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
2Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
3Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
5Center for Biomedicine and Community Health, International School, Vietnam National University, Hanoi, Vietnam
6Director Research and Innovation Centre, King Saud Medical City, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia
7Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, USA

Tài liệu tham khảo

World Health Organization. WHO coronavirus (COVID-19) Dashboard n.d. https://covid19.who.int/ (Accessed April 21, 2021). World Health Organization (WHO). Tracking SARS-CoV-2 variants 2021. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ (Accessed June 2, 2021). WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of Concern 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (Accessed December 10, 2021). Thakur V, Kanta Ratho R. OMICRON (B.1.1.529): a new SARS-CoV-2 variant of concern mounting worldwide fear. J Med Virol. 2021. https://doi.org/10.1002/JMV.27541. World Health Organization. Enhancing readiness for omicron (B.1.1.529): technical brief and priority actions for member states. World Heal Organ HQ 2021:1–8. https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states (Accessed December 25, 2021). Chen J, Wang R, Gilby NB, Wei G-W. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv 2021. Scott L, Hsiao N, Moyo S, Singh L, Tegally H, Dor G, et al. Track Omicron’s spread with molecular data. Science (80-). 2021;374:1454–5. https://doi.org/10.1126/science.abn4543. UK Health Security. COVID-19: Omicron daily overview - GOV.UK 2021. https://www.gov.uk/government/publications/covid-19-omicron-daily-overview (Accessed December 25, 2021). Ledford H. How severe are omicron infections? Nature. 2021;600:577–8. https://doi.org/10.1038/D41586-021-03794-8. Kupferschmidt K, Vogel G. How bad is Omicron? Some clues are emerging. Science. 2021;374:1304–5. https://doi.org/10.1126/SCIENCE.ACX9782. Eguia RT, Crawford KHD, Stevens-Ayers T, Kelnhofer-Millevolte L, Greninger AL, Englund JA, et al. A human coronavirus evolves antigenically to escape antibody immunity. PLoS Pathog. 2021. https://doi.org/10.1371/journal.ppat.1009453. Callaway E. Beyond omicron: what’s next for COVID’s viral evolution. Nature. 2021;600:204–7. https://doi.org/10.1038/D41586-021-03619-8. Wang R, Chen J, Wei G-W. Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America. J Phys Chem Lett. 2021. https://doi.org/10.1021/ACS.JPCLETT.1C03380. Graham F. Daily briefing: omicron—what scientists know so far. Nature. 2021. https://doi.org/10.1038/D41586-021-03652-7. Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. MedRxiv. 2021. https://doi.org/10.1101/2021.11.11.21266068. Liu C, Ginn HM, Dejnirattisai W, Supasa P, Wang B, Tuekprakhon A, et al. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021;184:4220-4236.e13. https://doi.org/10.1016/j.cell.2021.06.020. Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021;27:622–5. https://doi.org/10.1038/S41591-021-01285-X. Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization. Nature. 2021;596:276–80. https://doi.org/10.1038/s41586-021-03777-9. Dyer O. Covid-19: omicron is causing more infections but fewer hospital admissions than delta. South African data show Bmj. 2021;375: n3104. https://doi.org/10.1136/bmj.n3104. Wilhelm A, Widera M, Grikscheit K, Toptan T, Schenk B, Pallas C, et al. Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies. MedRxiv. 2021. https://doi.org/10.1101/2021.12.07.21267432. Lu L, Mok BW-Y, Chen L-L, Chan JM-C, Tsang OT-Y, Lam BH-S, et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. Clin Infect Dis. 2021. https://doi.org/10.1093/cid/ciab1041. Dejnirattisai W, Shaw RH, Supasa P, Liu C, Stuart AS, Pollard AJ, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. 2021. https://doi.org/10.1016/S0140-6736(21)02844-0. Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, et al. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. MedRxiv Preprin. 2021;11:12. https://doi.org/10.1101/2021.12.08.21267417. Quarleri J, Galvan V, Delpino MV. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. GeroScience. 2021. https://doi.org/10.1007/S11357-021-00500-4. Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV-2 variant: what we know and what we don’t. Anaesth Crit Care Pain Med. 2021;41: 100998. https://doi.org/10.1016/j.accpm.2021.100998. Doria-Rose NA, Shen X, Schmidt SD, O’Dell S, McDanal C, Feng W, et al. Booster of mRNA-1273 vaccine reduces SARS-CoV-2 omicron escape from neutralizing antibodies. MedRxiv Prepr Serv Heal Sci. 2021. https://doi.org/10.1101/2021.12.15.21267805. Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2021. https://doi.org/10.1016/S2213-2600(21)00559-2. Li X. Omicron: call for updated vaccines. J Med Virol. 2021. https://doi.org/10.1002/JMV.27530. Cohen J. Omicron sparks a vaccine strategy debateCurrent boosters, variant-specific shots, and universal coronavirus vaccines all have fans. Science (80-). 2021;374:1544–5. Kistler KE, Huddleston J, Bedford T. Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2. BioRxiv. 2021. https://doi.org/10.1101/2021.09.11.459844. Wang X, Powell CA. How to translate the knowledge of COVID-19 into the prevention of Omicron variants. Clin Transl Med. 2021. https://doi.org/10.1002/CTM2.680. He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 omicron variant: characteristics and prevention. MedComm. 2021;2:838–45. https://doi.org/10.1002/MCO2.110. Morens DM, Taubenberger JK, Fauci AS. Universal coronavirus vaccines—an urgent need. N Engl J Med. 2021. https://doi.org/10.1056/nejmp2118468.
Thông tin
Thông tin xuất bản

Journal of Epidemiology and Global Health

Tập 12

143-146

Thông tin tác giả